q&more
My watch list
my.chemie.de  
Login  

News

On our way to the bio-economy: High-performance biocatalyst discovered

Future applications primarily in the production of active pharmaceutical ingredients, but also in the synthesis of fine chemicals expected

Frank Hahn

Spatial structure of the enzyme AmbDH3.

22-May-2020: In the bioeconomy, biotechnological processes are replacing processes that rely on fossil resources. Microorganisms and enzymes are being used in targeted fashion as biocatalysts for industrial production. Researchers at the University of Bayreuth have now discovered an enzyme that offers great advantages as a biocatalyst. It is eminently suited for the production of natural product-derived drugs that promise a broad spectrum of medical application. Conventional synthesis processes for these substances are very laborious. In the journal "ACS Catalysis", researchers from the team of Prof. Dr. Frank Hahn present their discovery.

Biotechnological production of natural products and drugs

Nature holds a wealth of substances that could be of great medical benefits for humans. Due to their complex structures, however, these natural products can often only be produced at great expense when using conventional chemical processes. One promising approach to this problem is the use of biocatalysts, which often help to markedly simplify production. The new biocatalyst discovered by the Bayreuth researchers is the enzyme AmbDH3. It can be used to produce ring-shaped building blocks of natural products, so-called tetrahydropyrans. They often cause the biological activity of natural products, and therefore play an important role in medical applications.

In their study, the Bayreuth scientists succeeded in proving that AmbDH3 can be used to produce the antibiotically active (–)-centrolobin. On the basis of this, the Bayreuth research team intends to tackle the synthesis of further, even more complex tetrahydropyran-containing natural products. One example are the Bryostatins, which are of great interest in drug research due to their antiviral activity. They might even be suitable for the treatment of cancer or Alzheimer's disease.

A versatile and powerful biocatalyst

Tetrahydropyrans are ring-shaped molecules that belong to the chemical group of heterocycles. The research group of Prof. Dr. Frank Hahn at the University of Bayreuth shows, in its new study, that a variety of different heterocycles can be obtained with the help of the biocatalyst AmbDH3. The new biocatalyst has the advantage of allowing the spatial structure of the resulting ring-shaped molecules to be precisely controlled. In addition, AmbDH3 is a very stable enzyme and suitable for the production of large quantities of a desired substance. Until now, no biocatalyst has been known to combine all of these properties.

The scientists discovered AmbDH3 while studying bacteria that use this enzyme to produce ambruticin. This is a potential drug candidate for treatment of fungal diseases.

On our way to a sustainable bioeconomy

"I expect future applications for the enzyme AmbDH3 primarily in the production of active pharmaceutical ingredients, but also in the synthesis of fine chemicals. Our research group is confident that we will be able to discover further enzymes related to AmbDH3, which will further expand the repertoire of these biocatalysts. Our work has proven that biocatalysis can make a significant contribution to establishing a more natural resource-based economy. It thus contributes to solving central social challenges," says Hahn, who, together with his team at the University of Bayreuth, is conducting research into the drug potential of natural products, and the synthetic potential of biosynthetic enzymes.

Industrial (or “White”) biotechnology is indispensable in the development of a sustainable bio-economy. By allowing microorganisms or enzymes to take over the production of substances that were previously obtained by 'artificial' chemical synthesis processes, energy is conserved and significantly fewer toxic chemicals used. The chemical and pharmaceutical industries are very interested in such gentle processes. "With new biocatalysts, areas that until recently were reserved for traditional chemical synthetic methodology can be opened up to the bio-economy. In future, it will be important to combine the advantages of both research and development approaches in a targeted way," Hahn explains.

Original publication:
Tim Hollmann, Gesche Berkhan, Lisa Wagner, Kwang Hoon Sung, Simon Kolb, Hendrik Geise, Frank Hahn; "Biocatalysts from Biosynthetic Pathways: Enabling Stereoselective, Enzymatic Cycloether Formation on a Gram Scale"; ACS Catalysis; 2020

Facts, background information, dossiers

  • bioeconomy
  • biotechnology
  • biocatalysts
  • enzymes
  • natural products
  • active pharmaceutic…

More about Uni Bayreuth

  • News

    New perspectives for antibiotics research

    Researchers of the University of Bayreuth and the Columbia University in New York reported groundbreaking findings on protein biosynthesis in bacteria in the journal "iScience". The small protein NusG links the two large molecular machines that work together during gene expression, which is ... more

    Nitrogen – an exception in the periodic system?

    In the periodic table of elements there is one golden rule for carbon, oxygen, and other light elements. Under high pressures they have similar structures to heavier elements in the same group of elements. Only nitrogen always seemed unwilling to toe the line. However, high-pressure researc ... more

    New catalyst: easy on resources, less expensive, and highly selective

    Chemists at the University of Bayreuth have developed a sustainable, inexpensive, and at the same time potent catalytic process: it requires no rare precious metals and enables the targeted production of many fine chemicals, natural products, and medical agents. This opens up a broad spectr ... more

  • q&more articles

    Authentic food

    Authentic food is growing in popularity with consumers. In a heavily industrialized market, a regional, single-source and/or specially manufactured product is increasingly becoming a guarantor of greater value. In the premium segment in particular, economically motivated “food fraud” can re ... more

    More than honey?

    For thousands of years, the word “honey” has been synonymous with an all-natural, healthy food. Unsurprisingly, honey has also enjoyed unwavering popularity with consumers – and especially in times when organic food and a healthy lifestyle are more in vogue than ever before. more

    What Are We Eating?

    What ends up on our plates? We used to think we knew – until we were disabused of this notion in early 2013. Instead of beef, there had been large-scale use of processed horsemeat, especially in frozen products and mincemeat. Although this posed no hazard to health, the damage was enormous, ... more

  • Authors

    Dr. Christopher Igel

    completed his undergraduate studies in biochemistry at the University of Bayreuth from 2009 to 2013. He completed his bachelor’s dissertation entitled “Honey Analysis Using NMR” at the BIOmac research centre under the tutelage of Prof. Dr. Schwarzinger. more

    Wolfrat Bachert

    commenced his undergraduate studies in mechanical engineering at TU Dresden before moving to the University of Bayreuth in 2009 to study biology. In 2013, he completed his bachelor dissertation in the Dept. of Biochemistry under the tutelage of Prof. Dr. Wulf Blankenfeldt on the subject of ... more

    Prof. Dr. Stephan Clemens

    Stephan Clemens, Jg. 1963, studied biology in Münster and Brighton, then acquired his doctorate in Münster. Since his postdoc-stay at the University of California San Diego, his scientific interest has been mainly targeted at metal homoeostasis in plants. He uses the models Arabidopsis thal ... more

q&more – the networking platform for quality excellence in lab and process

The q&more concept is to increase the visibility of recent research and innovative solutions, and support the exchange of knowledge. In the broad spectrum of subjects covered, the focus is on achieving maximum quality in highly innovative sectors. As a modern knowledge platform, q&more offers market participants one-of-a-kind networking opportunities. Cutting-edge research is presented by authors of international repute. Attractively presented in a high-quality context, and published in German and English, the original articles introduce new concepts and highlight unconventional solution strategies.

> more about q&more

q&more is supported by:

 

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE